ArticleVeterinary research communications2026
Effects of dietary supplementation with chitosan nanogel on biochemical, antioxidant traits, and resistance to Aeromonas sobria infection, in Cyprinus carpio fingerlings.
Article in Veterinary research communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Effects of dietary chitosan-flaxseed oil nanoemulsion on growth, economic performance, immunity, intestinal health, and cold-stress resistance in Nile tilapia (Oreochromis niloticus).Veterinary research communications · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study was designed to evaluate the modulating effect of dietary chitosan nanogel (CHNG) on antioxidant status and hepato-renal function in Cyprinus carpio. Fish were allocated into 4 groups, each group consisted of 45 fish in triplicates, where each replicate was represented by an aquarium (15 fish/ aquarium). The prophylactic feeding trial lasted for sixty days, where fish were placed on either control, CHNG0.5%, 1% or 1.5%-supplemented diet, then, growth performance was assessed and serum samples was collected for biochemical and antioxidant assessments. Afterwards, fish in the four experimental groups were challenged with Aeromonas sobria,where clinical signs and mortalities were monitored over the fourteen-day challenge period. Then, tissue sampling was performed in order to assess the histopathological outcomes and hepatic gene expression in different groups. The outcomes revealed enhancement of hepato-renal function including ALT, AST, ALP, creatinine, and urea in CHNG-supplemented fish. The control group revealed a remarkable increase in tissue malondialdehyde (MDA) levels that was inhibited by CHNG supplementation in a level-related pattern. The activities of reduced glutathione (GSH), catalase (CAT), and superoxide dismutase (SOD) in liver tissue were significantly elevated in a dose-dependent manner in CHNG-supplemented groups. After A. sobria challenge, the hepatic gene expression showed that dietary supplementation with CHNG induced significant down-regulation of apoptosis-related signaling (cERK-1, JNK, P38, and Casp-8) compared with the control group which was challenged with A. sobria and received a basal diet devoid of CHNG. Interestingly, histopathological investigations showed a notable improvement in CHNG-fortified groups relative to the challenged group. Taken together, CHNG-dietary intervention is a potential candidate for enhancing the resistance to A. sobria infection in Cyprinus carpio.
Indexed as
Identifiers
42240902What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.